Skip to main content

Blood Glucose Meter Market to Expand at 9.6% CAGR and Reach USD 15,415.6 Million by 2026, Driven by Rising Uptake of Non-Invasive Meters, says Fortune Business Insights

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) — The global Blood Glucose Meter Market is likely to expand considerably in the coming years due to advent of non-invasive devices. According to a report published by Fortune Business Insights, titled “Blood Glucose Meters: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,419.0 Mn in 2018. Fortune Business Insights states that this market is likely to reach US$ 15,415.6 Mn by 2026, thereby exhibiting a CAGR of 9.6%.In this report, Fortune Business Insights has indicated that the market will grow in the near future due to the increasing demand and the subsequently rising uptake of blood glucose meters. Increasing incidence of diabetes has been a leading factor that is responsible for the surge in demand of blood glucose meters.According to the International Diabetes Federation (IDF), in 2017, around 425 million people suffered from diabetes, worldwide. Furthermore, it also states that this number is likely to reach 629 million by the year 2045. High prevalence of diabetes, combined with the accuracy of digital blood glucose meters in detecting blood pressure and sugar levels are driving the global Blood Glucose Meter Market.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-glucose-meters-market-100770
Launch of DiaMonTech’s IR-based Blood Glucose Meter to Spur Growth OpportunitiesConventional blood glucose meters involved the need for invasive techniques for diagnosis. The most commonly used methods involved taking blood samples with the help of needle pricks in fingers. The needle prick method was painful for many users and it caused discomfort to some. Therefore, there has been a constant need for an alternative to the invasive devices for continuous glucose monitoring.In 2018, DiaMonTech announced the launch of a compact blood glucose meter. The device performed on an infra-red technology that is used to count the glucose molecules. This product is likely to transform existing blood glucose monitoring techniques and is likely to witness high demand from around the world. The advent of non-invasive devices is likely to induce growth in the global Blood Glucose Meter Market.An Overview of the Impact of COVID-19 on this Market:The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-meters-market-100770

LifeScan and Sanvita Medical Collaborate to Develop Continuous Glucose Monitoring DevicesIn May 2019, LifeScan announced that it has reached an agreement with Sanvita Medical for development and marketing of continuous glucose monitoring (CGM) devices. Through this agreement, the company aims at making CGM devices available throughout North America and certain parts of Europe in initial years, with an aim of expanding in other parts of the world in the coming years.The company boasts an attractive product portfolio and its latest addition of CGM devices will bode well for the future business expansion. This partnership will have a positive impact on the global market and is likely to favor growth of the market in the coming years.Abbott’s Freestyle Libre Flash Glucose Monitoring Device Receives FDA ApprovalIn 2017, Abbott received clearance from the Food and Drug Administration for its Libre Flash device. The device was approved for patients with type 1 and type 2 diabetes, after a series of successful clinical trials. The blood glucose meter’s accuracy is expected to result in huge demand in the coming years. Abbott’s latest device is likely to bolster growth of the global Blood Glucose Meter Market and is likely to favor growth of the market in the forthcoming years.
Quick Buy –  Blood Glucose Meter Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100770
List of the leading companies operating in the global Blood Glucose Meter Market:F. Hoffmann-La Roche LtdDexcom, Inc.B. Braun Melsungen AGMedtronicLifespan Inc.Ascensia Diabetes Care Holdings AG.Terumo Medical CorporationAbbottSanofiDiaMonTech GmbH.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/blood-glucose-meters-market-100770
Blood Glucose Meter Market Segmentations:By Product           •              Continuous Glucose Monitoring Devices•              Self-Monitoring Blood Glucose (SMBG) SystemsBy Technique       •              Invasive•              Non-InvasiveBy Type •              Wearable•              Non-WearableBy Distribution Channel    •              Institutional Saleso              Hospitalso              Clinicso              Others•              Retail Saleso              Hospital Pharmacieso              Retail Pharmacieso              Online PharmaciesBy Geography      •              North America (USA and Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)•              Latin America (Brazil, Mexico and Rest of Latin America)•              Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/blood-glucose-meters-market-100770
Have a Look at Related Reports:Blood Glucose Monitoring Systems Market Share & Industry Analysis, By Device (Continuous Blood Glucose Monitoring Systems, Self-monitoring of Blood Glucose Systems), By Type (Invasive, Non-invasive), By Modality (Wearable, Non-wearable), By Distribution Channel (Institutional Sales, Retail Sales), and Regional Forecast 2019-2026Orthodontics Market Share & Industry Analysis, By Product Type [Instruments and Supplies {Fixed (Brackets, Bands & Buccal Tubes, Archwires, and Others), and Removable (Aligners, Retainers, and Others)}], By End User (Hospitals, Dental Clinics, Others) and Regional Forecast, 2019-2026Surgical Stapling Devices Market Share & Industry Analysis, By Product Type (Powered, Manual), By Type (Disposable, Re-usable), By Application (Gynecology Surgery, Urology Surgery, General Surgery, Others), By Surgery Type (Open Surgery, Laparoscopic Surgery), By End-user (Hospitals, Speciality Clinics, Others) and Regional Forecast, 2019-2026Veterinary Diagnostics Market Share & Industry Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Hematology, Immunohistochemistry, Molecular Diagnostics, Diagnostic Imaging, Clinical Biochemistry, and Others), By Animal Type (Livestock and Companion), End-user (Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, and Others) and Regional Forecast, 2019-2026Urinary Drainage Bags Market Share & Industry Analysis, By Product (Leg Bags and Large Capacity Bags), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml, and more than 2000 ml), By Number of Chambers (Single Chamber, 2 Chamber, 3 Chamber), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care, and Others), and Regional Forecast 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/blood-glucose-meters-market-9150

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.